matchedPattern,context,lineNumber,columnNumber,publicationName
c.1483C>T,1	14	c.1483C>T	p.R495X	34	F	9	Yes	Yes	L	No,37,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1528A>G,2	14	c.1528A>G	p.K510E	39	M	15	Yes	Yes	B	No,38,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1561C>T,3	15	c.1561C>T	p.R521C	33	M	10	NA	Yes	NA	No,39,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1561C>T,4†	15	c.1561C>T	p.R521C	35	F	7	Yes	Yes	B	No†,40,7,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1562G>A,5	15	c.1562G>A	p.R521H	35	F	>36	NA	Yes	L	No,41,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1574C>T,15	c.1574C>T	p.P525L,43,5,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1540A>G,7	15	c.1540A>G	p.R514G	60	M	>96	NA	Yes	B	No,45,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.2392C>T,FA-1	EUFA1333	FANCJ	IVS11–498A>T c.2392C>T	Hematopoietic mosaicism	[25],69,34,Anemia_2010_Jul_18_2010_565268.txt
c.316G>A,(c.316G>A) was most strongly associated with WBSF i...,653,2,Anim_Genet_2012_Dec_27_43(6)_662-673.txt
c.328C>T,"...ss‐of‐function mutations, a premature stop codon (c.328C>T, p.Arg110*) and a donor splice‐site mutat...",42,218,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"...C>T, p.Arg110*) and a donor splice‐site mutation (c.840+2T>A, p.Glu281_Leu282Ins8), both of which ca...",42,273,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.328C>T,... One of the SNPs constitutes a nonsense mutation (c.328C>T) causing a premature translational stop (...,80,656,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"...MITF exon 3 (Fig. 2), whereas the other mutation (c.840+2T>A) introduces a donor splice‐site mutatio...",80,817,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.328C>T,"...1001150.2) causing a premature translational stop c.328C>T, p.Arg110* at genomic position chr22: 32 ...",82,265,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.328C>T,"...d at cDNA level in spotted buffaloes carrying the c.328C>T mutation, suggesting nonsense‐mediated de...",82,510,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"...(b) A donor splice‐site mutation (NM_001001150.2) c.840+2T>A, p.Glu281_Leu282Ins8 at position chr22:...",84,274,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.328C>T,"...Genotype frequencies of the MITF nonsense variant c.328C>T, p.Arg110* (chr22: 32 322 242a) and the s...",88,59,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"... (chr22: 32 322 242a) and the splice‐site variant c.840+2T>A, p.Glu281_Leu282Ins8 (chr22: 32 297 683...",88,128,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.1326T>G,"The SNP c.1326T>G in the non‐SMC condensin I complex, subu...",1143,9,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
c.1698C>T,...uence showed 2 common heterozygous polymorphisms: c.1698C>T in exon 10 and c.2095C>A in exon 12. The...,26,289,Ann_Dermatol_2013_Nov_30_25(4)_483-488.txt
c.2095C>A,...erozygous polymorphisms: c.1698C>T in exon 10 and c.2095C>A in exon 12. The FACE1 (ZMPSTE24) sequenc...,26,314,Ann_Dermatol_2013_Nov_30_25(4)_483-488.txt
c.2249C>A,...tions comprised c.1947dupC (p.Pro649Profs*11) and c.2249C>A (p.Ser750*). The most recently reported ...,33,503,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1538-1G>A,"..., had a homozygous acceptor splice site mutation, c.1538-1G>A. The third case, from Pakistan, had a ...",48,400,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1883G>C,"...rom Pakistan, had a homozygous missense mutation, c.1883G>C (p.Arg628Pro) that occurred within the e...",48,480,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1045G>T,"...erlands) was also a homozygous missense mutation, c.1045G>T (p.Ala-349Ser)16, as was the mutation in...",48,703,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1387C>T,"...349Ser)16, as was the mutation in the fifth case, c.1387C>T (p.Arg463Trp)17. Clues to the molecular ...",48,770,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1538-1G>A,"...eleterious effects of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin struc...",51,1441,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1312C>T,"...5 gene was performed and the pathogenic mutation, c.1312C>T (p.Arg438Cys), was identified. Interesti...",3,1961,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
c.1312C>T,... analysis of GDF5 revealed a missense mutation at c.1312C>T that resulted in a change in the protein...,17,487,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
c.1312C>T,...ysis of the GDF5 gene. A heterozygous mutation of c.1312C>T in exon 2 is noted,30,71,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
c.763G>A,"...twice, and a missense mutation [ABL1 NM_005157.4: c.763G>A (p.Glu255Lys)] was newly detected in the ...",15,762,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
c.763G>A,...e ABL1 gene was changed from G to A [NM_005157.4: c.763G>A (p.Glu255Lys)],25,491,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
c.3766C>T,"...terozygous mutations, c.1153dupG (p.Val385fs) and c.3766C>T (p.Arg1256X), in EIF2AK4. Unaffected par...",18,394,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.3766C>T,"...pG, and the father carried the nonsense mutation, c.3766C>T).13 Ten additional sporadic PCH case pat...",18,607,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.860-1G>A,"...ient had a compound heterozygous splice mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p....",18,865,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.3438C>T,"...ce mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were identifi...",18,902,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.280A>G,"...s influencing beef flavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located...",8,550,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...ing beef flavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2...",8,560,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...lavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 ...",8,570,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...r types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 of the FABP4 ...",8,583,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...ickness, GG genotypes were the lowest at 11.91 in c.280A>G SNP (p<0.04), for marbling score, c.388G>...",45,576,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"....91 in c.280A>G SNP (p<0.04), for marbling score, c.388G>A SNPs were the highest at 5.66 in GG genot...",45,619,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...h has a high proportion of saturated fatty acids, c.408G>C SNP was the highest at 25.61, 25.79 in GG...",45,817,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,... the highest at 45.08 and 54.43 in GG genotype of c.280A>G SNP (p<0.05) and 44.56 and 53.84 in GG ge...,47,185,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...NP (p<0.05) and 44.56 and 53.84 in GG genotype of c.388G>A SNP (p<0.05). Also, they had higher conte...",47,245,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...es, since their composition in the CC genotype of c.408G>C SNP, GG genotype of c.456A>G SNP were 45....",47,405,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...n the CC genotype of c.408G>C SNP, GG genotype of c.456A>G SNP were 45.71, 54.74 and 45.06, 54.40, r...",47,434,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon ...",51,26,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon...",51,49,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...e block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon 4. Haplot...",51,59,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon 4. Haplotypic associations of blo...",51,83,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...id and MUFA among the fatty acids. In particular, c.280A>G SNP had an association with back fat thic...",54,259,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...sociation with back fat thickness, and in case of c.388G>A SNP, with marbling score. Also, it has be...",54,331,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"Among these four SNPs, c.280A>G and c.388G>A are non-synonymous SNPs that...",58,24,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"Among these four SNPs, c.280A>G and c.388G>A are non-synonymous SNPs that have a chang...",58,37,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...he nucleotide changes. Especially, in the case of c.280A>G SNP, as ATC nucleotide into GTC, changes ...",58,177,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,...the encoded amino acid from isoleucine to valine. c.388G>A SNP is also a non-synonymous SNP where va...,58,277,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...G nucleotide changes into ATG. On the other hand, c.408G>C and c.456A>G are synonymous SNPs, which d...",58,407,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...changes into ATG. On the other hand, c.408G>C and c.456A>G are synonymous SNPs, which do not have ch...",58,420,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...do have nucleotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an asso...",58,545,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...cleotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an association wi...",58,555,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...homozygous genotypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an i...",62,71,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"... genotypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased p...",62,81,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"... with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion ...",62,91,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"... and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion of oleic acid...",62,104,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...ordingly, it is expected that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at ...",66,54,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"... it is expected that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3...",66,63,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...ected that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3, and 4 ar...",66,73,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...lotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3, and 4 are able to incr...",66,87,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	F1	TTGACATTTTTCTTTTCCCAAC	200,99,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.193T>G,c.193T>G	2	F	TTGACATTTTTCTTTTCCCAAC	200,102,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.212C>A,c.212C>A	2	F	TATAGGCGTGGGCTTTGCTA	202,105,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,c.280A>G	2	F	GGGGTGTGGTCACCATTAAA	178,108,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.352T>G,c.352T>G	3	F	CAAGGGCGATTGTCTATTTCTC	208,111,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.364T>C,c.364T>C	3	F	TTATGGGATGACCTAGCACTAAAA	201,114,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,c.388G>A	3	F	ATTATCCCCACAGAGCATCG	219,117,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,c.408G>C	3	F	CATCGTAAACTTAGATGAAGGTGCT	200,120,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,c.456A>G	4	F	TTCCTGCTCAACATTGAAGG	190,123,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	L41V	T,135,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.193T>G,c.193T>G	2	L45V	T,139,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.212C>A,c.212C>A	2	T51N	C,143,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,c.280A>G	2	I74V	A,147,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.352T>G,c.352T>G	3	W98G	T,151,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.364T>C,c.364T>C	3	S102P	T,155,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,c.388G>A	3	V110M	G,159,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,c.408G>C	3	L116L	G,163,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,c.456A>G	4	A132A	A,167,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,5,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,14,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,23,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,32,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,7,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,16,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,25,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,34,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.349T>C,...o et al. (2011) reported that the polymorphism of c.349T>C in the CRBP II gene would be genetically ...,47,1289,Asian-Australas_J_Anim_Sci_2014_Mar_27(3)_310-315.txt
c.12669G>A,"...iginal ArticleRole of the APOB Gene Polymorphism (c.12669G>A, p. Gln4154Lys) in Coronary Artery Dise...",3,223,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...D). The association of the APOB gene polymorphism c.12669G>A, p.Gln4154Lys with the risk of CAD vari...",3,1287,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...ation. We have studied the APOB gene polymorphism c.12669G>A, p.Gln4154Lys and its relationship with...",3,1568,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...able variation in linking APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) with CAD risk in differen...",8,1384,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...nt study, the role of the APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) was studied in native Ind...",28,63,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.1523A>T,... in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive...,193,129,Biomed_Res_Int_2013_Jul_11_2013_283985.txt
c.9C>G,"...ne whether there is a link between the rs2073618 (c.9C>G, G1181C) and rs3134069 (g.119964988A>C, T24...",22,107,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
c.9C>G,rs2073618 (c.9C>G)	 	 	 ,113,12,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
c.9C>G,(c.9C>G),143,2,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
c.1799T>A, c.1799T>A	p.V600E	56 (29.9),189,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1801A>G, c.1801A>G	p.K601E	11 (5.9),192,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.34G>A, c.34G>A	p.G12S	1 (0.5),194,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	34 (18.2),196,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61K	5 (2.7),197,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	7 (3.7),199,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61K	6 (3.2),200,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.183G>T, c.183G>T	p.Q61H	1 (0.5),201,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	8 (4.3),203,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61H	1 (0.5),204,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1799T>A, c.1799T>A	p.V600E	51,244,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1801A>G, c.1801A>G	p.K601E	6,246,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.34G>A, c.34G>A	p.G12S	1,248,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	29,250,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61K	7,251,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	4,253,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61K	3,254,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	2,256,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.80G>A,... on the absence of association between the common c.80G>A polymorphism (rs1051266) of the gene codin...,19,187,Biomed_Res_Int_2015_Jan_14_2015_135931.txt
c.769C>T,"A1	M	58	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,47,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"...58	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,56,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.879+1G>A,"A2	M	47	AADC, GAD, TPH	HP, D, V	c.879+1G>A/c.879+1G>A",22,33,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.879+1G>A,"A2	M	47	AADC, GAD, TPH	HP, D, V	c.879+1G>A/c.879+1G>A",22,44,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A3	F	54	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,45,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.1336T>G,"...	54	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,55,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A4	F	25	21OH, 17OH	A	c.769C>T / c.1242_1243insA",24,22,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A5	F	20	21OH, SCC, 17OH	C, A, V, N, G	c.769C>T/c.1242_1243insA",25,39,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A6	M	21	21OH, SCC, 17OH, AADC	C, HP, A, K	c.769C>T/c.769C>T",26,43,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"...6	M	21	21OH, SCC, 17OH, AADC	C, HP, A, K	c.769C>T/c.769C>T",26,52,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.1273C>T,...cal hemolytic uremic syndrome associated with the c.1273C>T mutation in the complement C3 gene Cho H...,3,337,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,"... mutations are a well-known etiology of aHUS, the c.1273C>T mutation has never been reported in Cauc...",12,62,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,...s that the penetrance of aHUS associated with the c.1273C>T mutation in the complement C3 gene is lo...,25,865,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,.... This means that a heterozygous carrier with the c.1273C>T mutation of C3 itself may not develop aH...,25,1189,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,The c.1273C>T mutation is located within the C3 gene d...,27,5,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,...e suspect that the pathogenesis of aHUS caused by c.1273C>T is likely to be associated with dysregul...,27,144,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,"...the first Korean case of aHUS associated with the c.1273C>T mutation in the complement C3 gene, wher...",29,426,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,...orphism analysis of our patient with heterozygote c.1273C>T mutation in C3 gene showing 250 bp produ...,36,91,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.35G>T,... genomic hybridization. A KRAS codon 12 mutation (c.35G>T; p.G12V) was detected in the pyloric gland...,7,891,BMC_Cancer_2012_Dec_4_12_570.txt
c.35G>T,"...nd 2 showed a point mutation at exon 1, codon 12 (c.35G>T; p.G12V) and wildtype sequence at exon 2 i...",55,91,BMC_Cancer_2012_Dec_4_12_570.txt
c.34G>C,"...tonin, somatostatin, gastrin	KRAS exon 1 (p.G12R; c.34G>C)",83,180,BMC_Cancer_2012_Dec_4_12_570.txt
c.35G>T,"..., negative: MUC2, CD10, CDX2	KRAS exon 1 (p.G12V; c.35G>T); CGH: gains at 1q, 6p11p22, 7p, 15q, 20p,...",96,160,BMC_Cancer_2012_Dec_4_12_570.txt
c.1699G>A,c.1699G>A	p.Ala567Thr	rs1803274,41,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.6637G>A,c.6637G>A	p.Asp2213Asn	rs529038,44,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.-238C>T,c.-238C>T		rs1800849,47,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.599C>T,c.599C>T	p.Pro200Leu	rs1050450,50,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.526C>T,c.526C>T	p.Arg176Cys	rs7412,56,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.1307C>A,c.1307C>A	p.Thr436Lys	rs4588,65,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.300C>T,c.300C>T	p.Asp100=	rs1799986,71,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.81C>T,c.81C>T	p.Cys27=	rs2228671,74,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.1699G>A,"...led that only the rs1803274 polymorphism of BCHE (c.1699G>A, p.Ala567Thr) was associated with an inc...",250,178,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.1194A>G,Exon 12	c.1194A>G	NA	p.L398L	benign	AA 9/39; AG 12/39; GG ...,36,9,BMC_Gastroenterol_2012_Oct_15_12_141.txt
c.1814G>A,Exon 17	c.1814G>A	NA	p.R605Q	unknown	1/39 (het: Pt-7) (0.0...,37,9,BMC_Gastroenterol_2012_Oct_15_12_141.txt
c.451C>T,"...ent (e.g. the allele frequency of the T allele of c.451C>T, p.R151C, was 1.9% in Greece but 10.2% in...",171,663,BMC_Genet_2008_Apr_10_9_31.txt
c.2881C>T,"...eceptor (EGFR) inhibitors; however, a KDR p.R961W c.2881C>T mutation was noted as a variant of unkno...",9,1250,Cureus_8(2)_e478.txt
c.2881C>T,"...ceptor (EGFR) inhibitors, however the KDR p.R961W c.2881C>T mutation that was noted as a variant of ...",26,720,Cureus_8(2)_e478.txt
c.2881C>T,...biomarker of response to regorafenib. KDR p.R961W c.2881C>T mutation has been reported twice in COSM...,50,1099,Cureus_8(2)_e478.txt
c.-964A>G,"rs153109, corresponding to position c.-964A>G of the IL-27 locus, was amplified from g...",7,37,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
c.406C>T,...led the presence of previously reported mutations c.406C>T (p.Arg110>Cys) in two families (family A&...,12,390,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.475C>T,...T (p.Arg110>Cys) in two families (family A&B) and c.475C>T (p.Arg133>Cys) mutation in family C,12,447,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,A	Saudi	c.406C>T	3	p.Arg110>Cys	EGF2	ND,40,9,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,B	Kuwait	c.406C>T	3	p.Arg110>Cys	EGF2	ND,41,10,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,"...OTCH3 gene, revealed the presence of heterozygous c.406C>T (p.Arg110>Cys) pathogenic mutation in exo...",55,804,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,...OTCH3 gene; revealed the presence of heterozygous c.406C>T (p.Arg110>Cys) pathogenic mutation in exo...,58,729,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.475C>T,...sence of a previously known heterozygous mutation c.475C>T (p.Arg133>Cys) in exon 4 [1]. This mutati...,61,699,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.471G>A,"...ries. Two of the single nucleotide substitutions, c.471G>A and c.807G>A and the insertion (c.388+3in...",12,387,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.807G>A,"...the single nucleotide substitutions, c.471G>A and c.807G>A and the insertion (c.388+3insT) were clos...",12,400,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,"...sversion in the last base of intron 7, g.3912G>C (c.808-1G>C) so altering the consensus acceptor spl...",12,620,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,"...ngle nucleotide substitutions were transversions: c.101A>T, c.995G>C and c.670 T>G that result in p....",12,837,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.995G>C,"...otide substitutions were transversions: c.101A>T, c.995G>C and c.670 T>G that result in p.E34V, p.G3...",12,847,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,I	P	F	35	2.4	2.9	1212	8.80	896	+/-	c.471G>A/del exon5,47,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,M	F	64	1.2	1.1	120	1.21 (619)	70	-/-	c.471G>A/del exon5,48,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,Si	F	27	1.2	2.4	1975	9.20	371	+/-	c.471G>A/del exon5,50,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,III	P	F	35	9.2	21.6	4032	7.80	485	+/+	c.808-1G>C/r.spl?,52,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,C	F	28	1.1	0.8	97	1.70	127	-/-	c.808-1G>C/r.spl?,53,33,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,C	F	33	ND	ND	ND	ND	ND	-/-	c.808-1G>C/r.spl?,54,28,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,V	P	F	26	1.3	1.6	149	10.40	2411	+/-	c.101A>T/p.E34V,56,37,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,Si	F	31	1.2	2.1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,VI	P	F	16	8.0	18.5	2619	10.12	ND	-/+	c.101A>T/p.E34V,58,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,VIII	P	F	40	2.4	4.2	874	5.50	1030	+/+	c.670T>G/p.W224R,67,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,D	F	15	0.9	1.4	34	1.28 (619)	ND	-/-	c.670T>G/p.W224R,69,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,A	F	45	2.5	2.3	450	11.77	893	+/+	c.670T>G/p.W224R,70,35,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,So	M	18	1.1	1.2	35	1.15 (619)	ND	-/-	c.503G>A/p.R168H,110,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,So	M	19	0.9	0.6	86	120	ND	-/-	c.503G>A/p.R168H,112,32,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,Si	F	35	ND	ND	ND	3.15	1281	+/-	c.503G>A/p.R168H,113,33,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.532T>G,XXV	P	F	27	3.1	4.0	870	5.40	1592	+/-	c.532T>G/p.L178V,117,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.317A>C,XXVI	P	F	39	4.4	6.2	307	5.33	1214	+/-	c.317A>C/p.H106P,118,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,...e G to A transitions in the last bases of exon 5 (c.471G>A) (Figure 2a) and exon 7 (c.807 G>A) (Figu...,181,216,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,III	P	13.15	39.55	c.808-1G>C/r.spl?,193,19,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,C	15.58	46.85	c.808-1G>C/r.spl?,194,16,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,C	16.85	50.67	c.808-1G>C/r.spl?,195,16,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,V	P	18.48	55.58	c.101A>T/p.E34V,197,17,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,20,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,D	18.12	54.19	c.670T>G/p.W224R,202,16,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,"...n A to T substitution at nucleotide position 101 (c.101A>T) (Proband V and VI, Figure 5) which resul...",209,159,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,...e was a T to G change at nucleotide position 670 (c.670T>G) leading to a tryptophan to a glycine sub...,209,583,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...ree of them were single nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other w...",238,292,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,"...nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other was a small insertion. In...",238,316,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...cryptic splicing site [34]. However, only for the c.471G>A mutation (Figure 2a), which affects the d...",238,532,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,"...were transversions leading to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and...",240,91,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.995G>C,"...ng to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10 respectively. They w...",240,115,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.-22T>C,...52610.1186/1471-2350-10-29Research ArticleA novel c.-22T>C mutation in GALK1 promoter is associated ...,3,128,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"Three nucleotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to...",12,49,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...leotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T...",12,60,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...tutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C mutation, G...",12,74,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...9A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C mutation, GALK1 activity in 13 subjects w...",12,104,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"The c.-22T>C mutation, which was observed frequently i...",15,5,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,...CCT CAC CAT AG-3') primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 ...,36,434,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,...-3') primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 healthy adults...,36,448,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...ntified in the promoter region of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and th...",49,419,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...the promoter region of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the presence ...",49,430,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...egion of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the presence of these polym...",49,444,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...as confirmed by performing PCR-RFLP (Fig. 1). For c.-179A>G, 56 subjects with A/A genotype, 5 with A...",49,554,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...type and 2 with G/G genotype were identified. For c.-27A>C, 61 individuals had A/A genotype and 2 sh...",49,661,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...101 normal individuals, suggesting that two SNPs, c.-179A>G and c.-27A>C, are benign sequence variat...",49,896,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...ividuals, suggesting that two SNPs, c.-179A>G and c.-27A>C, are benign sequence variations. In terms...",49,910,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...7A>C, are benign sequence variations. In terms of c.-22T>C, 50 individuals with T/T, 12 with T/C, an...",49,964,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"... than polymorphism. Genotype distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did no...",49,1259,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...orphism. Genotype distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate f...",49,1270,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...type distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate from those exp...",49,1283,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,c.-179A>G	A/A	56	117.2 ± 41.7	0.012	1.39 ± 2.06	0....,56,1,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,c.-27A>C	A/A	61	112.1 ± 41.7	0.173	1.34 ± 0.46	0.4...,60,1,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,c.-22T>C	T/T	50	96.1 ± 24.3	<0.001	1.16 ± 0.25	<0....,64,1,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,...Sequencing revealed the presence of a mutation of c.-22T>C (A). Gel electrophoresis patterns of PCR ...,69,128,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...gments digested with BsgI for the confirmation of c.-22T>C (B) are shown (Lane M, DNA size marker; l...",69,245,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...7 of GALK1 (Table 1), which further suggests that c.-27A>C is a nonfunctional polymorphism",71,980,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"To test if c.-22T>C affected transcription, reporter analysis...",80,12,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...wo and a half fold increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase ac...",80,471,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...fold increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase activity was not...",80,485,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,Figure 3 c.-22T>C mutation resulted in increased reporter a...,82,10,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,... determine if the elevated luciferase activity of c.-22T>C was due to alterations in the binding of ...,84,72,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,...E activities. We found that the nucleotide change c.-22T>C in the promoter region of GALK1 gene was ...,89,834,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...as promoter activity. The reporter construct with c.-22T>C enhanced luciferase activity, both in the...",91,255,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...with the EMSA result, this data suggests that the c.-22T>C resulted in an increased abundance of the...",91,498,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...ar proteins that bind to the GALK1 promoter, with c.-22T>C, will be necessary to elucidate the mecha...",97,368,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,The c.-22T>C of GALK1 gene was frequently observed in ...,100,5,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.1849G>T,...veral groups have reported a somatically acquired c.1849G>T point mutation in exon 14 of JAK2 gene (...,18,524,BMC_Med_Genet_2010_Apr_1_11_54.txt
c.1194T>A,"...athogenic variants (c.1740delC, c.2975_2978delAG, c.1194T>A, c.1780G>A, c.4819C > T) were identified...",10,72,BMC_Med_Genet_2010_May_26_11_79.txt
c.1780G>A,"...ariants (c.1740delC, c.2975_2978delAG, c.1194T>A, c.1780G>A, c.4819C > T) were identified in the gro...",10,83,BMC_Med_Genet_2010_May_26_11_79.txt
c.1780G>A,"... c.1194T > A/p.D398E, c.1740delC/p.s581PfsX40 and c.1780G>A/p.E594K. Two columns are sequencing chro...",52,180,BMC_Med_Genet_2010_May_26_11_79.txt
c.574+1G>A,"...erozygote at this gene. One of these alterations, c.574+1G>A, is located at the splice donor site of...",7,750,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,...equencing analysis. It has been proposed that the c.574+1G>A mutation would cause exon 5 skipping du...,7,1085,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...e importantly, we provide evidence that the novel c.2206-2A>G mutation also disrupts normal NTRK1 sp...",7,1252,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,Figure 2 Characterization of the effect of IVS 5 (c.574+1G>C) and IVS16 (c.2206-2A>G) point mutation...,36,51,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,...on of the effect of IVS 5 (c.574+1G>C) and IVS16 (c.2206-2A>G) point mutations on NTRK1 splicing. A....,36,74,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,... C change disrupting the 5' splice site of IVS 5 (c.574+1G>C). The second mutation is an A to G chan...,38,213,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,...change that disrupts the 3'splice site of IVS 16 (c.2206-2A>G). Both the father and sister of the pa...,38,309,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"... of the patient were shown to be carriers for the c.2206-2A>G mutation, whereas her mother was shown...",38,399,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,"...reas her mother was shown to be a carrier for the c.574+1G>C mutation. To the best of our knowledge,...",38,474,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,...t change affecting the first nucleotide of IVS 5 (c.574+1G>A) has been reported in an earlier study ...,38,694,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 spli...,40,35,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 splicing, we carrie...",40,50,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,".... This analysis, therefore, demonstrates that the c.574+1G>C mutation causes exon 5 skipping. Skippi...",42,351,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...deletion of the first 21 bp of exon 17. Thus, the c.2206-2A>G mutation leads to the production of tw...",42,1016,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,"...e mother of the patient, who is a carrier for the c.574+1G>C mutation, whereas the mRNA variants wit...",42,1698,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...d sister of the proband, who are carriers for the c.2206-2A>G mutation",42,1891,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,...mal splicing of NTRK1 mRNA. One of the mutations (c.574+1G>C) disrupts the 5' splice site of IVS 5. ...,44,306,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,"...ote, a different mutation of the same nucleotide (c.574+1G>A) was previously detected in a patient w...",44,410,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,"...ch an effect was provided. Here, we show that the c.574+1G>C change does, in fact, lead to skipping ...",44,608,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...5. The second mutation identified in our patient (c.2206-2A>G) disrupts the 3'splice site of IVS 16,...",44,716,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,"...ents [6,14]. The skipping of exon 5 caused by the c.574+1G>C mutation introduces a frame shift that ...",44,1312,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...ed, non-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the...",44,1456,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2944C>T,"...ion and sequence change. For example, NM_020975.4:c.2944C>T refers a C→T substitution happened at po...",40,293,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
c.350G>A,"...or example (Figure 1.4), the mutation NM_000492.3:c.350G>A (id: M301052)in gene CFTR is associated w...",50,808,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
c.1313G>A,...wo missense mutations were identified in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp51...,37,636,BMC_Neurol_2011_Oct_1_11_119.txt
c.1531G>A,...ified in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in families MCP35 and MCP3...,37,668,BMC_Neurol_2011_Oct_1_11_119.txt
c.900C>A,5	c.900C>A	Cys300X	Exon 8	Indian	[4],55,3,BMC_Neurol_2011_Oct_1_11_119.txt
c.1204C>T,...ients with the Parkin mutations (the heterozygous c.1204C>T mutation in exon 11 and c.458C>G mutatio...,183,599,BMC_Neurosci_2016_Feb_1_17_6.txt
c.458C>G,...he heterozygous c.1204C>T mutation in exon 11 and c.458C>G mutation in exon 4 of Parkin). In the lit...,183,633,BMC_Neurosci_2016_Feb_1_17_6.txt
c.799G>A,"c.799G>A/c.85C > A		(mean 12.34, range 0.88-23.80)...",87,1,BMC_Pediatr_2010_Nov_17_10_82.txt
c.278C>T,3	TCA>TTA	c.278C>T	Ser93Leu	Hydrophilic to hydrophobic	In pr...,90,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.427G>A,4	GAG> AAG	c.427G>A	Glu143Lys	Acidic to basic	Polymorphism,91,12,BMC_Womens_Health_2005_May_26_5_8.txt
c.531C>T,4	AGC>AGT	c.531C>T	Ser177Ser	Silent	Polymorphism,92,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1086C>G,4	GGC>GGG	c.1086C>G	Gly362Gly	Silent	Polymorphism,96,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1250C>T,4	Ccg>Ctg	c.1250C>T	Pro417Leu	Potential tertiary structure c...,97,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1406C>T,5	GCG>GTG	c.1406C>T	Ala469Val		Polymorphism,98,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1541G>A,6	GGG>GAG	c.1541G>A	Gly514Glu	Small hydrophobic to acidic	On...,99,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1809T>C,9	TTC>TTT	c.1809T>C	Phe603Leu	Aromatic to aliphatic	Polymorp...,100,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1998C>T,11	CAC>CAT	c.1998C>T	His666His	Silent	Polymorphism,101,12,BMC_Womens_Health_2005_May_26_5_8.txt
c.2621T>A,16		c.2621T>A			3' untranslated region. Polymorphism,102,5,BMC_Womens_Health_2005_May_26_5_8.txt
c.1541G>A,...uding brain tumors and leukemias). The underlying c.1541G>A nucleotide substitution was detected in ...,107,793,BMC_Womens_Health_2005_May_26_5_8.txt
c.936+919G>A,... a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,491,104,BMJ_Open_2016_Apr_8_6(4)_e010422.txt
c.154A>C,"...agic telangiectasia type 2 with a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL1 gene Neu...",240,139,Bone_Res_2015_Apr_14_3_15005.txt
c.564T>C,"... GTL2 promoter DMR, heterozygosity at a DLK1 SNP (c.564T>C) (n=−2) or at closely linked microsatelli...",36,572,Br_J_Cancer_2005_Apr_25_92(8)_1574-1580.txt
c.980A>C,...ent changes were observed (Table 1). A Pro327Pro (c.980A>C) change in exon 5 and a Pro1297Pro (c.389...,25,411,Br_J_Cancer_2005_Mar_28_92(6)_1126-1129.txt
c.3890C>G,...Pro (c.980A>C) change in exon 5 and a Pro1297Pro (c.3890C>G) change in exon 27 were both found in 4%...,25,456,Br_J_Cancer_2005_Mar_28_92(6)_1126-1129.txt
c.8672G>A,...tained kinase activity. One missense ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G substitution...,10,363,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...sense ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G substitution were identified. In the modell...,10,394,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,"...st cancer. The presence of the missense mutation, c.7271T>G (p.Val2424Gly), further increases the ri...",21,250,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"Two ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), w...",56,20,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"Two ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), were identified in the cells fr...",56,50,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"... was carried on each allele of chromosome 11, the c.8672G>A mutation was paternal and the c.1A>G mut...",56,391,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...e 11, the c.8672G>A mutation was paternal and the c.1A>G mutation maternal in origin",56,431,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...y result in expression of mutant ATM protein. The c.1A>G affects the first base in the coding sequen...,58,126,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...GUG in the RNA was able to allow translation. The c.8672G>A (p.Gly2891Asp) is a missense mutation lo...,58,433,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...omain. It was expected that at the cDNA level the c.8672G>A mutation might result in loss of exon 60...,58,597,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,"...lowing a severe reaction to radiotherapy (A-T109, c.7271T>G homozygous) (Stankovic et al, 1998). Alt...",63,229,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,"...gh the level of ATM expression was highest in the c.7271T>G cells, the level of kinase activity appe...",63,332,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...nt A-T86, carrying the initiating codon mutation, c.2T>C, on one allele and a null mutation on the s...",66,108,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...n a truncated protein. In translational terms the c.1A>G mutation in A-T213 would be expected to beh...,66,506,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...on in A-T213 would be expected to behave like the c.2T>C mutation as both mutations are in the initi...,66,569,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"... than that immunoprecipitated from cells from the c.2T>C patient A-T86 (Figure 5, lanes 7 and 8) but...",68,165,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...ells (Figure 5, lanes 1 and 2). Assuming that the c.1A>G and c.2T>C mutant alleles result in a simil...",68,289,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...e 5, lanes 1 and 2). Assuming that the c.1A>G and c.2T>C mutant alleles result in a similar level of...",68,300,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...rotein in cells from patient A-T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncated ATM ass...,68,441,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...Truncated ATM associated with the presence of the c.1A>G mutation was not detected, probably because...",68,524,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"...e it was obscured by the full-length ATM from the c.8672G>A (p.Gly2891Asp) allele (Figure 5, compare...",68,623,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...e finding that the ATM protein expressed from the c.2T>C mutant allele in the LCL from patient A-T18...,68,795,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,"...lele that was essentially full-length p.Arg3047X (c.9139C>T) (Figure 5, lanes 9 and 10)",68,965,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...precipitated from A-T cells carrying the mutation c.2T>C, which did not demonstrate any in vitro kin...",70,152,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...e activity in cells of patient A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,316,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...cDNA. Both the mutant protein associated with the c.1A>G and the p.Gly2891Asp mutant protein are sho...,72,242,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...rotein are shown in Figure 6A. Interestingly, the c.1A>G protein was of lower molecular weight than ...",72,328,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"... mutant protein was significantly higher than the c.1A>G protein (Figure 6A, lanes 4 and 5). We were...",72,643,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"... unlikely to be due to protein expressed from the c.1A>G mutation. Indeed, the mutant c.1A>G ATM clo...",74,269,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...ssed from the c.1A>G mutation. Indeed, the mutant c.1A>G ATM cloned into pMEP4 was expressed as a lo...",74,305,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...ase-inactive truncated protein expressed from the c.2T>C ATM mutant,74,457,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"...of this mild presentation, the two ATM mutations, c.8672G>A (p.Gly2891Asp) and c.1A>G, in patient A-...",77,657,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...e two ATM mutations, c.8672G>A (p.Gly2891Asp) and c.1A>G, in patient A-T213 are both of considerable...",77,686,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"Interestingly, the c.8672G>A missense mutation was reported in one of...",79,20,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,... ATM protein derived from the allele carrying the c.1A>G mutation affecting the initiating methionin...,81,54,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...e way as a protein derived from another mutation (c.2T>C) in the same codon. Cells from a patient wi...,81,180,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,... in the same codon. Cells from a patient with the c.2T>C and an ATM-null mutation expressed a trunca...,81,237,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...nase activity. Therefore, it is unlikely that the c.1A>G derived protein has any activity. In both c...",81,378,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...ar weight of ATM immunoprecipitated from both the c.2T>C mutant cells and the modelled c.1A>G is con...,81,676,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...rom both the c.2T>C mutant cells and the modelled c.1A>G is consistent with this,81,713,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...that the truncated ATM protein expressed from the c.1A>G and c.2T>C mutant alleles is the result of ...,83,140,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...uncated ATM protein expressed from the c.1A>G and c.2T>C mutant alleles is the result of uncharacter...,83,151,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,"...east cancer, were homozygous for the ATM mutation c.7271T>G (p.Val2424Gly). The mutation was also id...",85,1041,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1918A>T,...utations in novel premature termination mutation (c.1918A>T (Lys640Stop)) and a (c.1066-6T>G (IVS10-...,87,284,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1066-6T>G,"...mination mutation (c.1918A>T (Lys640Stop)) and a (c.1066-6T>G (IVS10-6T-G)), which has previously be...",87,315,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8147T>C,"...y (Mandigers et al, 2011). Only one ATM mutation (c.8147T>C (p.Val2716Ala)), which also has some ATM...",87,686,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...of two mutant ATM proteins, (p.Gly2891Asp and the c.1A>G derived protein) raises the possibility of ...",89,334,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,... evidence of a significant effect of the inactive c.1A>G derived protein in reducing the activity of...,89,524,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...ons at these positions in patient A-T213; (A) the c.1A>G mutation, and (B) the c.8672G>A mutation. T...",108,205,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"...ient A-T213; (A) the c.1A>G mutation, and (B) the c.8672G>A mutation. The boxed sequence triplet in ...",108,234,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...th, the ATM in an LCL from patient A-T86 with the c.2T>C mutation (and also null mutation c.7665deli...",112,507,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...es 7 and 8). It is likely that truncated ATM from c.2T>C in patient AT187 is obscured by the p.Arg30...,112,659,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,...C in patient AT187 is obscured by the p.Arg3047X (c.9139C>T) mutant protein (lanes 9 and 10) and the...,112,714,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...otein (lanes 9 and 10) and the truncated ATM from c.1A>G in patient A-T213 is obscured by the p.Gly2...,112,784,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...n patient A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutant protein (lanes 5 and 6). Immunop...,112,842,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...f A-T213 but not from ATM of patient A-T86 with a c.2T>C mutation and a second truncating mutation (...,112,1314,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...g mutation (lane 8) or from patient A-T187 with a c.2T>C mutation and c.9139C>T (p.Arg3047X). (B) Hi...,112,1402,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,...or from patient A-T187 with a c.2T>C mutation and c.9139C>T (p.Arg3047X). (B) Histogram of relative ...,112,1422,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...of expression than the protein expressed from the c.1A>G mutation. (A) ATM protein without tags. ATM...,114,137,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"... Overexposure of the western blot showed that the c.1A>G derived protein (1A>G, lane 4) is truncated...",114,347,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,...st cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Br...,131,290,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1066-6T>G,...s associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Fa...,131,304,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.280C>T,"...A patient carrying a heterozygous RPS19 mutation (c.280C>T, p.Arg94X), and healthy control samples w...",77,279,Br_J_Haematol_2015_Nov_25_171(4)_517-529.txt
c.5882G>A,ARDM-135	42	24	0.4	0.6	STGD	c.5882G>A(42)	p.Gly1961Glu	c.1029_1030insT(8)	p.As...,76,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5882G>A,ARDM-240	15	13	0.2	0.16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762G...,77,30,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.2285C>A,...40	15	13	0.2	0.16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762Glu	Yes,77,57,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5882G>A,ARDM-225	32	25	0.25	0.50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187...,78,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6559C>T,...5	32	25	0.25	0.50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187X	Yes,78,58,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Y...,79,24,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.700C>T,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,51,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-162	50	16	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	Yes,80,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-198	27	19	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	NP,81,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3056C>T,ARDM-146	32	13	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047...,86,30,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6140T>A,...46	32	13	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047Asn	Yes,86,57,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3056C>T,ARDM-40	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315...,87,27,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3943C>T,...M-40	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,54,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5929G>A,ARDM-90	26	8	Hand moving	STGD	c.5929G>A (43)	p.Gly1977Ser	IVS21-2A>T		Yes,88,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3323G>A,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,30,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.4793C>A,ARDM-197	35	15	0.1	0.1	STGD	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5...,90,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5172G>T,...GD	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,76,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6079C>T,ARDM-183	63	55	0.150	0.175	STGD	c.6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (false –)...,91,33,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5929G>A,...63	55	0.150	0.175	STGD	c.6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (false –)	p.Gly1977Ser (false –)	NP,91,60,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.1804C>T,ARDM-38	35	6	0.01	0.02	STGD	c.1804C>T(13)	p.Arg602Trp	c.4739delT(33)	p.Leu1580...,92,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.4457C>T,ARDM-163	48	32	0.01	0.32	STGD	c.4457C>T(30)	p.Pro1486Leu	ND	ND	Yes,93,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6320G>A,ARDM-166	42	39	NA	STGD	c.6320G>A(46)	p.Arg2107His	ND	ND	Yes,94,24,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.2791G>A,ARDM-222	26	23	NA	STGD	c.2791G>A(19)	p.Val931Met	ND	ND	NP,95,24,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.4919G>A,ARDM-205	NA	NA	NA	STGD	c.4919G>A(35)	p.Arg1640Gln	ND	ND	NP,98,24,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-247	30	12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137...,99,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6410G>A,...247	30	12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Tyr	Yes,99,56,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.4297G>A,ARDM-99	59	46	0.05	0.05	CRD	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,100,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.2701A>G,ARDM-131	27	15	0.9	0.7	CRD	c.2701A>G(18)	p.Thr901Ala	ND	ND	Yes,101,28,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.466A>G,RP-959	53	10	0.1	0.1	RP	c.466A>G(5)	p.Ile156Val	ND	ND	Yes,105,25,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.4297G>A,RP-1058	37	6	0.2	0.6	RP	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,106,25,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.1029T>C,8	c.1029T>C	p.Asn343Asn	This study,117,3,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.1299A>G,10	c.1299A>G	p.Glu433Glu	This study,118,4,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.1654G>A,12	c.1654G>A	p.Val552Ile	This study,119,4,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.2832A>G,19	c.2832A>G	p.Pro944Pro	This study,121,4,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.2964C>T,20	c.2964C>T	p.Leu988Leu	18,122,4,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3507G>A,23	c.3507G>A	p.Gln1169Gln	This study,123,4,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.446C>T,4	2	Reduced	Traces	Mild reduction	Exome	Exon 2: c.446C>T; p.(Pro149Leu)	Exon 3: c.643C>T; p.(Gln21...,98,49,Brain_2013_Jan_3_136(1)_269-281.txt
c.643C>T,...ion	Exome	Exon 2: c.446C>T; p.(Pro149Leu)	Exon 3: c.643C>T; p.(Gln215*),98,81,Brain_2013_Jan_3_136(1)_269-281.txt
c.1183A>T,...Exon 8: c.1114_1116del; p.(Val372del)	Exon 9: Het c.1183A>T; p.(Arg395*),99,167,Brain_2013_Jan_3_136(1)_269-281.txt
c.2T>G,...bres negative	Mild reduction	Exome/Sanger	Exon 1: c.2T>G; p.(M1_R59del)	Exon 2: c.377G>A; p.(Arg126H...,100,72,Brain_2013_Jan_3_136(1)_269-281.txt
c.377G>A,...xome/Sanger	Exon 1: c.2T>G; p.(M1_R59del)	Exon 2: c.377G>A; p.(Arg126His),100,102,Brain_2013_Jan_3_136(1)_269-281.txt
c.157G>A,...ild reduction on some fibres	Exome/Sanger	Exon 1: c.157G>A; p.(Ala53Thr)	Exon 9: c.1183A>T; p.(Arg39...,101,97,Brain_2013_Jan_3_136(1)_269-281.txt
c.1183A>T,...ome/Sanger	Exon 1: c.157G>A; p.(Ala53Thr)	Exon 9: c.1183A>T; p.(Arg395*),101,128,Brain_2013_Jan_3_136(1)_269-281.txt
c.677A>G,...Sanger	Exon 1: c.53dup; p.(Ser19Glufs*97)	Exon 3: c.677A>G; p.(Tyr226Cys),102,96,Brain_2013_Jan_3_136(1)_269-281.txt
c.1183A>T,"...op codon mutation in exon 9: g.chr7:16255759 T>A, c.1183A>T, p.Arg395* and a heterozygous in-frame t...",116,579,Brain_2013_Jan_3_136(1)_269-281.txt
c.377G>A,"...mutation in exon 2: g.chr7:16445843 C>T, which is c.377G>A, leading to p.Arg126His. Interestingly, t...",116,860,Brain_2013_Jan_3_136(1)_269-281.txt
c.2T>G,"...gous mutation affecting the start codon in exon 1 c.2T>G, leading to p.M1_R59del or p.M1?, was ident...",116,987,Brain_2013_Jan_3_136(1)_269-281.txt
c.157G>A,...ous mutation was found by Sanger sequencing to be c.157G>A causing p.Ala53Thr located in exon 1. All...,121,222,Brain_2013_Jan_3_136(1)_269-281.txt
c.677A>G,...dupT) in exon 1 and a missense mutation in exon 3 c.677A>G (p.Tyr226Cys). The heterozygous carrier s...,123,629,Brain_2013_Jan_3_136(1)_269-281.txt
c.364-1G>A,...n Patient 1) in cis with the splice site mutation c.364-1G>A (IVS3-1g>a). Previous expression studie...,153,945,Brain_2014_May_18_137(5)_1350-1360.txt
c.364-1G>A,"...1g>a). Previous expression studies concluded that c.364-1G>A is a pathogenic mutation (Mills et al.,...",153,1012,Brain_2014_May_18_137(5)_1350-1360.txt
c.7271T>G,...al population-based study of a specific mutation (c.7271T>G) in ATM [18] and the recent report of tw...,64,780,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
c.7271T>G,...st cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Br...,128,285,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
c.1066-6T>G,...s associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Fa...,128,299,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
c.-87T>C,"...n of the exon 4 (rs2016520, referred as T+294C or c.-87T>C); this polymorphism is located at the lin...",114,640,Cardiovasc_Diabetol_2008_Jul_25_7_23.txt
c.4719C>T,...tions. Her genotype showed a splice-site mutation c.4719C>T in exon 27 of the SCN5A gene. This rare ...,35,779,Case_Rep_Anesthesiol_2016_Sep_7_2016_9278409.txt
c.1376C>G,"c.1376C>G, p.Ser459Ter",52,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2691G>A,"c.2691G>A, p.Trp897Ter",55,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2575C>T,c.2575C>T,61,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.829C>T,"c.829C>T, p.Arg277Ter",65,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.984C>A,"c.984C>A, p.Tyr328Ter",67,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2455C>T,"c.2455C>T, p.Arg630X",68,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.4462C>T,"c.4462C>T, p.Arg1488X",70,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.4975A>T,"c.4975A>T, p.Lys1450X",75,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1126A>C,"c.1126A>C, p.K376Q",79,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.984C>A,"c.984C>A, p.Y328X	Ahmad et al., 2007 [15]",85,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2687G>A,"c.2687G>A, p.R896Q",89,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1567C>T,"c.1567C>T, p.Arg523Ter	Kurban et al., 2010 [17]",96,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2697G>A,"c.2697G>A, p.Met899Ile",100,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.5155T>C,c.5155T>C; C1719R,106,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1567C>T,"c.1567C>T, p.Arg523Ter",112,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.3598G>A,"...ected a heterozygous mutation in the COL2A1 gene (c.3598G>A; p.Gly1200Ser). This missense mutation, ...",26,163,Case_Rep_Obstet_Gynecol_2015_Sep_8_2015_935204.txt
c.1003C>T,...ting results confirmed the presence of the R335X (c.1003C>T) mutation in the PTEN gene and the patie...,33,62,Case_Rep_Oncol_Med_2015_Sep_10_2015_546297.txt
c.1622T>C,"... a mutation in the ABCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozyg...",15,659,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.3113C>T,"...BCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,679,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.1622T>C,"...s mutations in exons 12 and 21 of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a he...",29,588,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.3113C>T,"... 12 and 21 of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous variant i...",29,608,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.227G>A,"...heterozygous variant in exon 2 of the NR2E3 gene (c.227G>A, p.R760), and (3) a heterozygous variant ...",29,686,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.747A>T,...a heterozygous variant in exon 6 of the RGR gene (c.747A>T p.K249N). Based on previous knowledge of ...,29,763,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.1622T>C,"...genes, it was concluded that the ABCA4 mutations (c.1622T>C, p.L541P; c.3113C>T, p.A1038V) were thos...",29,875,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.3113C>T,"...ded that the ABCA4 mutations (c.1622T>C, p.L541P; c.3113C>T, p.A1038V) were those that likely caused...",29,895,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.1622T>C,"...disease-causing alleles in the ABCA4 gene, L541P (c.1622T>C, p.Leu541Pro, rs61751392) and A1038V (c....",33,182,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.3113C>T,"... (c.1622T>C, p.Leu541Pro, rs61751392) and A1038V (c.3113C>T, p.Ala1038Val, rs61751374), were identif...",33,230,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.335G>A,"... the nucleotide position 5234 (exon 2: g.5234G>A, c.335G>A, p.Arg112His) described in the literature...",46,381,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
c.1299G>A,...enes RAG1 or RAG2 revealed a homozygous missense (c.1299G>A) mutation in the RAG1 gene. This is the ...,10,116,Cases_J_2009_Jul_30_2_8391.txt
c.1299G>A,... patient revealed a homozygous missense mutation (c.1299G>A) in the RAG1 gene leading to replacement...,28,1731,Cases_J_2009_Jul_30_2_8391.txt
c.1299G>A,"... patient revealed a homozygous missense mutation (c.1299G>A) in the RAG1 gene, which led to the repl...",34,83,Cases_J_2009_Jul_30_2_8391.txt
c.1299G>A,...Omenn’s syndrome in which this missense mutation (c.1299G>A) was detectable in a patient who was het...,34,360,Cases_J_2009_Jul_30_2_8391.txt
c.1565C>T,"...prisingly, only 1 missense mutation (rs138651238; c.1565C>T and p.T522M) was discovered (Fig. 6). In...",87,217,Cell_Adh_Migr_2016_Feb_6_10(1-2)_395-55.txt
c.1432A>G,"...nt or function. The homozygous missense mutation (c.1432A>G, N478D) in the MTPAP gene was singled ou...",21,1168,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
c.542G>A,... patient was hemizygous for the nonsense mutation c.542G>A in exon 6 of the FHL1 gene. Other genes w...,11,474,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
c.542G>A,"The mutation, c.542G>A, locates in exon 6 and is a novel nonsens...",18,15,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
c.542G>A,"...nce of four and a half LIM domain 1 isoforms. The c.542G>A locates on exon 6, the resultant p.Trp181...",22,89,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
c.542G>A,"...ese case of FHL1 mutation associated HCM, and the c.542G>A (p.181W>X) is a novel nonsense mutation. ...",24,118,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
c.1615G>A,"...analysis showed the girl to be homozygous for the c.1615G>A, p.(Asp539Asn) missense mutation in GPI....",16,727,Clin_Case_Rep_2015_Oct_7_3(10)_862-865.txt
c.845G>A,"...n the seventh month of life. She was carrying the c.845G>A (p.C282Y) mutation in heterozygosis, conf...",27,202,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.742A>G,".... This study showed a missense mutation in BMPR2, c.742A>G (p.R248G) located in exon six, and anothe...",33,153,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.760G>A,"...ated in exon six, and another mutation in ACVRL1, c.760G>A (p.D254N. These mutations are described f...",33,225,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.742A>G,...these computer programs labeled it as pathogenic. c.742A>G was considered pathogenic by all but Poly...,33,628,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.760G>A,...red pathogenic by all but Polyphen‐2 software and c.760G>A by all but Pmut software. The other genes...,33,698,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.731T>C,A c.731T>C CAPN5 mutation resulted in a p.Leu244Pro ...,10,3,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
c.728G>T,"...munohistopathological features of two eyes with a c.728G>T, p.Arg243 Leu mutation in CAPN5.5 We foun...",22,720,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
c.731T>C,"...and one brother (Figure 1). This family carried a c.731T>C, p.Leu244Pro mutation in the CAPN5 gene.1...",28,211,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
c.731T>C,Notes: A c.731T>C mutation in CAPN5 was inherited in a domi...,61,10,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
c.1894G>T,NR3C2 mutation (c.1894G>T; p.E632X). The arrow indicates th,50,17,Clin_Pediatr_Endocrinol_2016_Oct_18_25(4)_135-138.txt
c.2830G>A,c.2830G>,50,1,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
c.-949C>T,"... of NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL...",9,77,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-352A>T,"... (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), T...",9,105,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"...49C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), a...",9,131,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"...352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629...",9,158,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"...>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) polymorphisms with breast ca...",9,188,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"... of IL-8 polymorphism, GA and AA genotypes of TNF c.-418G>A polymorphism, and GA genotype of TNF c.-...",15,404,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"...NF c.-418G>A polymorphism, and GA genotype of TNF c.-488G>A polymorphism significantly reduced breas...",15,451,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-949C>T,"... of NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL...",22,619,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-352A>T,"... (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), T...",22,647,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"...49C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), a...",22,673,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"...352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629...",22,700,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"...>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) polymorphisms with breast ca...",22,730,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-949C>T,"For NFKBIA c.-949C>T (rs2233406) polymorphism, the forward pr...",31,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-352A>T,"For IL-8 c.-352A>T (rs4073) polymorphism, the forward prime...",33,10,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"For IL-10 c.-854T>C (rs1800871) polymorphism, the forward pr...",35,11,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"For TNF c.-418G>A (rs361525) polymorphism, the primers use...",37,9,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"For TNF c.-488G>A (rs1800629) polymorphism, the primers us...",39,9,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"... of IL-8 polymorphism, GA and AA genotypes of TNF c.-418G>A polymorphism, and GA genotype of TNF c.-...",320,238,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"...NF c.-418G>A polymorphism, and GA genotype of TNF c.-488G>A polymorphism significantly reduced breas...",320,285,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.1A>T,"1	c.1A>T, c. 13G>A",288,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.29G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A...",289,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.34G>C,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.43G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.52G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,30,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.92C>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,39,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.95A>C,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,48,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.97C>T,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101...",291,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.98G>A,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>G",291,10,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.101A>G,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>G",291,46,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.110C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.118C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.124C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.125G>A,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.125G>C,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.136G>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.16...",295,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.136G>C,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.160T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,47,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.164C>T,"c.164C>T, c.167T>A",297,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.167T>A,"c.164C>T, c.167T>A",297,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.235G>T,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, ...",298,19,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.245C>A,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376d...",298,29,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.256G>A,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del40, c.39...",298,39,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.300G>C,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del40, c.397_399delCC...",298,49,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.310C>T,"...221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del40, c.397_399delCCA, c.428A>...",298,59,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.428A>G,"...00G>C, c.310C>T, c.337_376del40, c.397_399delCCA, c.428A>G",298,102,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.434G>A,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.458V>G,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.483A>T,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.497G>A,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.500G>A,"c.500G>A, c.511C>T, c.518C>T",301,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.511C>T,"c.500G>A, c.511C>T, c.518C>T",301,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.518C>T,"c.500G>A, c.511C>T, c.518C>T",301,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.574A>C,"5	c.536delG, c.574A>C, c.574A>G, c.600C>G",302,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.574A>G,"5	c.536delG, c.574A>C, c.574A>G, c.600C>G",302,24,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.600C>G,"5	c.536delG, c.574A>C, c.574A>G, c.600C>G",302,34,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.632A>G,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.633A>T,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.634T>G,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,34,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.635G>A,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,44,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.645C>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.688G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.701G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.714G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.719C>G,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.719C>T,"c.719C>T, c.727G>A, c.730G>A",307,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.727G>A,"c.719C>T, c.727G>A, c.730G>A",307,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.730G>A,"c.719C>T, c.727G>A, c.730G>A",307,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.758G>A,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, ...",308,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.758G>T,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.759C>G,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.766C>T,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.772G>A,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,43,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.794A>G,"...c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,53,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.799T>C,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, ...",310,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.804T>A,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.813A>T,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.814C>A,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.818A>G,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.823C>T,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,51,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.838G>A,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.848T>C,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.850G>C,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.865T>G,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.892A>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.893T>G,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.930G>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.931C>T,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.933G>T,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,43,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.983G>A,"9	c.968_973delGTGTCC, c.971delT, c.983G>A, c.1000C>T",314,34,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1000C>T,"9	c.968_973delGTGTCC, c.971delT, c.983G>A, c.1000C>T",314,44,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1001G>A,"c.1001G>A, c.1015G>T, c.1041_1042delGA, c.1046_104...",316,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1015G>T,"c.1001G>A, c.1015G>T, c.1041_1042delGA, c.1046_1047delAA",316,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1051A>C,"c.1051A>C, c.1076G>A",318,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1076G>A,"c.1051A>C, c.1076G>A",318,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1096C>T,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1097G>A,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,15,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1138G>C,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,26,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1180G>A,"11	c.1175_1176delGA, c.1180G>A, c.1183G>T, c.1186A>G",320,22,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1183G>T,"11	c.1175_1176delGA, c.1180G>A, c.1183G>T, c.1186A>G",320,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1186A>G,"11	c.1175_1176delGA, c.1180G>A, c.1183G>T, c.1186A>G",320,44,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1192G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1204C>T,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1205G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1225G>T,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,34,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1244C>A,"c.1244C>A, c.1252T>C, c.1283_1284insA",324,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1252T>C,"c.1244C>A, c.1252T>C, c.1283_1284insA",324,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1286G>A,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321...",325,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1289G>A,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330...",325,15,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1292G>T,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,26,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1310C>T,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,37,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1321T>C,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,48,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1330G>C,"...6G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,59,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1335G>A,"c.1335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, ...",327,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1358G>A,"c.1335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, c.1393G>A",327,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1372A>C,"c.1335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, c.1393G>A",327,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1393G>A,"c.1335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, c.1393G>A",327,51,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.110C>T,"Screening for P37L and P37= (c.110C>T, c.111G>A) in exon 2 and E310D in exon 8 ...",28,30,Curr_Genomics_2015_Aug_16(4)_215-223.txt
c.111G>A,"Screening for P37L and P37= (c.110C>T, c.111G>A) in exon 2 and E310D in exon 8 of PRKN wa...",28,40,Curr_Genomics_2015_Aug_16(4)_215-223.txt
c.1120C>T,"...o IPS were identified recently: missense mutation c.1120C>T in a highly conserved region of exon 8,1...",66,972,Dermatoendocrinol_2011_Apr_1_Apr-Jun_3(2)_53-61.txt
c.99+1G>A,... novel heterozygous intron 1 splice site variant (c.99+1G>A) in both the index individual and the fa...,5,1885,Dev_Med_Child_Neurol_2014_Nov_29_56(11)_1124-1128.txt
c.99+1G>A,... This revealed a splice site variant in intron 1 (c.99+1G>A) in both the index individual and in the...,31,1194,Dev_Med_Child_Neurol_2014_Nov_29_56(11)_1124-1128.txt
c.128G>A,"...ons in each of the three probands: R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E2...",34,101,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.203G>A,"...probands: R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A,...",34,126,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.742G>A,"...3His and c.203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), ...",34,167,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.675C>G,"...Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R and D217N (c.781...",34,193,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.781G>A,"... and c.675C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). ...",34,238,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.649G>A,"...), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of these six mutations, fi...",34,264,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.232A>G,2	c.232A>G	p.Thr78Ala	CGL2	[27],98,3,Diagn_Pathol_2013_May_9_8_78.txt
c.263A>G,"2	c.263A>G	p.Asn88Ser	dHMN	[16,18,28]",99,3,Diagn_Pathol_2013_May_9_8_78.txt
c.269C>T,"2	c.269C>T	p.Ser90Leu	dHMN, CMT2	[18,29,30]",100,3,Diagn_Pathol_2013_May_9_8_78.txt
c.269C>G,"2	c.269C>G	p.Ser90Trp	dHMN, CMT2	[22]",101,3,Diagn_Pathol_2013_May_9_8_78.txt
c.272T>C,2	c.272T>C	p.Leu91Pro	CGL2	[27],102,3,Diagn_Pathol_2013_May_9_8_78.txt
c.412C>T,3	c.412C>T	p.Arg138X	CGL2	[5],103,3,Diagn_Pathol_2013_May_9_8_78.txt
c.560A>G,4	c.560A>G	p.Tyr187Cys	CGL2	[15],104,3,Diagn_Pathol_2013_May_9_8_78.txt
c.565G>T,4	c.565G>T	p.Glu189X	CGL2	[14],105,3,Diagn_Pathol_2013_May_9_8_78.txt
c.634G>C,"5	c.634G>C	p.Ala212Pro	CGL2	[5,25]",106,3,Diagn_Pathol_2013_May_9_8_78.txt
c.684C>G,6	c.684C>G	p. Tyr228X	CGL2	[7],107,3,Diagn_Pathol_2013_May_9_8_78.txt
c.823C>T,7	c.823C>T	p.Arg275X	CGL2	[31],108,3,Diagn_Pathol_2013_May_9_8_78.txt
c.1171C>T,10	c.1171C>T	p.Gln391X	CGL2	[27],109,4,Diagn_Pathol_2013_May_9_8_78.txt
c.-2548G>A,"...imentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjec...",142,109,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
c.57C>T,"...tions in the DYF13 gene, a one-base substitution (c.57C>T) and a one-base deletion (c.59delC; Figure...",94,909,eLife_2014_Mar_4_3_e01566.txt
c.745C>A,"... L239P, R263Q, R263X, E425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Gr...",24,166,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
c.228-16C>G,"...63Q, R263X, E425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Green (2008)...",24,176,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
c.228-22T>A,"...425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Green (2008), Labauge et ...",24,189,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
c.673C>T,"...we found a homozygous nucleotide change in XRCC4 (c.673C>T), predicted to introduce a premature stop...",9,794,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
c.673C>T,...The most severe variant was the nucleotide change c.673C>T in XRCC4. Two different isoforms of XRCC4...,88,677,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
c.320C>T,c.320C>T	p.Ser107Leu	Ig-like C2-type 1 domain	Dise...,140,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.1342C>T,c.1342C>T	p.Arg448Trp	Juxta-membrane domain	Diseas...,144,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.2314C>T,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-caus...,147,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.2314C>T,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-caus...,150,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.253C>T,c.253C>T	p.Arg85Cys	First intracellular loop	Disea...,153,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.743G>A,c.743G>A	p.Arg248Glu	Third intracellular loop	Poly...,156,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.1157C>A,...4.1) gene revealed two novel genetic alterations: c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p...,57,962,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
c.1412T>G,...lterations: c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p.Leu471Arg) in exon 9 (Fig. 1) Targete...,57,1000,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
c.554G>A,"...	Newborn period	18 months	Inherited, heterozygous c.554G>A (R185Q)	Saline, phosphate, and cholecalci...",110,137,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, furosemide, and pamidrona...",114,22,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.206G>A,"...90 mg daily	6 years	6 years	Inherited, homozygous c.206G>A (R69H)	Pamidronate, phosphate, hydration	...",117,87,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, low calcium formula, phos...",119,22,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, low calcium formula, and ...",121,22,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.2753T>C,"...n our case a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy) was detected by targeted n...",4,1178,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
c.2753T>C,"...h revealed a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy), further validated by Sang...",31,235,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
c.444C>A,...entified two de novo heterozygous mutations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p....,4,887,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
c.557C>T,"... mutations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R193X)) in the STAR gene, causing...",4,920,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
c.4154A>T,"... novel heterozygous ABCC8 gene missense mutation (c.4154A>T/ p.Lys1385Thr), who was initially respon...",4,562,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
c.4154A>T,... for a novel missense mutation in the ABCC8 gene (c.4154A>T/p.Lys1385Thr). Since the lysine residue ...,31,384,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
c.1621G>A,...ing peripheral leukocytes revealed a heterozygous c.1621G>A mutation in the MEN1 gene that was previ...,10,70,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,"...nd direct DNA sequencing, we found a heterozygous c.1621G>A (Ala541Thr) mutation at exon 10 of the M...",56,91,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,"...y identified [9]. In this patient, a heterozygous c.1621G>A (Ala541Thr) mutation was found on exon 1...",63,586,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,...olyPhen-2 report indicates that the heterogeneous c.1621G>A (Ala541Thr) mutation is predicted to be ...,86,199,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.582T>A,"...hermore, two other TMPRSS3 mutations (NM_024022.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.58...",10,977,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
c.581G>T,...2.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.581G>T; NP_076927.1:p.C194F) were detected in th...,10,1023,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
c.521T>C,"..., the SNPs were different at different races. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130A...",148,187,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.388A>G,...fferent races. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP were the common mutatio...,148,218,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.521T>C,"...re found in more and more studies. Specially, the c.521T>C (p.Val174Ala) SNP has been associated wit...",150,113,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.388A>G,The c.388A>G and the c.521T>C variants occur in allele...,162,5,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.521T>C,The c.388A>G and the c.521T>C variants occur in alleles of OATP1B1*15. ...,162,22,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.521T>C,...ously described association between the rs4149056 c.521T>C polymorphism in the solute carrier organi...,422,227,Eur_J_Epidemiol_2015_Sep_19_30_661-708.txt
c.521T>C,...er LE  Uitterlinden AG  Klungel OH    The SLCO1B1 c.521T>C polymorphism is associated with dose decr...,974,96,Eur_J_Epidemiol_2015_Sep_19_30_661-708.txt
c.151+1G>T,"...ction (LOF) single-nucleotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1...",3,1987,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...single-nucleotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and ...",3,1999,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"...leotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-o...",3,2009,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...ymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-function ...",3,2020,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...P; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-function SNP (c.489C>T)...",3,2034,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,...3A>C and c.1729T>A) and one gain-of-function SNP (c.489C>T). The purpose of this study was to determ...,3,2075,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...ects on P2X7R function.32 The most common variant c.1513A>C, produces an amino acid change at positi...",18,229,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...talloproteinase-9 from macrophages.17, 33, 34 The c.1729T>A variant (p.I568N) abolishes trafficking ...",18,507,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...icking of the receptor to the cell surface,35 the c.946G>A variant (p.Arg307Gln) abolishes ATP bindi...",18,600,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"...nding to the extracellular domain of P2X7R,36 the c.1096C>G variant (p.Thr357Ser) results in reduced...",18,697,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,...regulation of P2X7R expression32 and the intronic c.151+1G>T variant results in a null allele.37 The...,18,837,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,"...F variants results in ablated ATP response.37 The c.489C>T variant (p.His155Tyr), located in the ext...",18,1170,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"... one or more minor allele for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.17...",34,67,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"... minor allele for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while ...",34,79,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"...ele for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while having maj...",34,89,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...OF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while having major alleles ...",34,100,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...her c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while having major alleles at the other ...",34,113,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"Overall, SNP call rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c....",41,38,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"... call rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>G (rs2230911) and c...",41,63,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"...r c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>G (rs2230911) and c.1729T>A (rs1653624) an...",41,86,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"... c.946G>A (rs28360457), c.1096C>G (rs2230911) and c.1729T>A (rs1653624) and 95% for c.489C>T (rs2082...",41,112,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,...(rs2230911) and c.1729T>A (rs1653624) and 95% for c.489C>T (rs208294) and c.1513A>C (rs3751143). Tab...,41,146,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,...A (rs1653624) and 95% for c.489C>T (rs208294) and c.1513A>C (rs3751143). Table 2 shows the predicted...,41,170,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lowe...,43,7,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...six previously published P2RX7 SNPs revealed that c.946G>A (p.Arg307Gln) was significantly associate...,44,67,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,... change in LS-BMD did not differ significantly by c.946G>A genotype (−0.39%/year (SEM 0.06) for GG s...,44,735,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"...ions (n=84), subjects who had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.172...",47,135,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"... who had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almos...",47,156,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almost ninefold ...",47,167,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...ther c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almost ninefold greater annua...",47,180,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...endorff et al22 demonstrated that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), a...",50,860,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"... that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associated with an increa...",50,888,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...d an association of a major LOF SNP in P2RX7, the c.946G>A (p.Arg307Gln), with low BMD in the LS in ...",52,78,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...ounding effects on bone loss or baseline BMD. The c.946G>A polymorphism changes arginine to glutamin...,52,606,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...Permeability studies of subjects heterozygous for c.946G>A (Figure 1 in Gu et al, 200436) show compl...",52,979,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...nt on function even in heterozygous dosage. Thus, c.946G>A may be classified as a dominant-negative ...",52,1173,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...one turnover. Indeed, the profound effects of the c.946G>A SNP on bone are further highlighted and r...",52,1340,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...found that subjects who were heterozygous for the c.946G>A (Arg307Gln variant) had >40% greater bone...,52,1501,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,... with total hip replacement revision and that the c.946G>A allele increased cumulative hazard of tot...,52,1875,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"...ment revision.46 In our study, heterozygosity for c.151+1G>T that leads to one null allele37 had no ...",52,1989,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...MD, while neither of the most prevalent variants, c.1513A>C, nor c.1729T>A polymorphisms alone showe...",52,2103,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...er of the most prevalent variants, c.1513A>C, nor c.1729T>A polymorphisms alone showed any significa...",52,2118,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...fracture risk. As the observed effect size of the c.946G>A is quiet large (β=0.12) compared with pre...,60,178,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...xamine rare genetic variants, including the P2RX7 c.946G>A, which has a population frequency of arou...",60,849,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,rs35933842	c.151+1G>T	0.01	1.00 (0.01)	0.98 (0.04)	*	0.4	−0.0...,88,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,rs208294	c.489C>T (p.H155Y)	0.43	0.99 (0.01)	1.01 (0.01)	1....,89,10,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,rs28360457	c.946G>A (p.R307Q)	0.02	1.00 (0.01)	0.88 (0.03)	*	...,90,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,rs2230911	c.1096C>G (p.T357S)	0.07	1.00 (0.01)	1.03 (0.02)	1...,91,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,rs3751143	c.1513A>C (p.E496A)	0.17	1.00 (0.01)	1.00 (0.02)	1...,92,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,rs1653624	c.1729T>A (p.I568N)	0.02	1.00 (0.01)	0.99 (0.03)	1...,93,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,rs35933842	c.151+1G>T	0.01	0.97 (0.01)	0.93 (0.03)	*	0.3	−0.0...,105,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,rs208294	c.489C>T (p.H155Y)	0.43	0.96 (0.01)	0.98 (0.01)	0....,106,10,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,rs28360457	c.946G>A (p.R307Q)	0.02	0.97 (0.01)	0.84 (0.04)	*	...,107,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,rs2230911	c.1096C>G (p.T357S)	0.07	0.97 (0.01)	0.98 (0.02)	1...,108,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,rs3751143	c.1513A>C (p.E496A)	0.17	0.97 (0.01)	0.97 (0.01)	0...,109,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,rs1653624	c.1729T>A (p.I568N)	0.02	0.97 (0.01)	0.93 (0.02)	1...,110,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.458C>T,... specific. The most common identified to date are c.458C>T (p.(Pro153Leu))1 and c.913G>T (p.(Glu305*...,21,475,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.913G>T,"...ntified to date are c.458C>T (p.(Pro153Leu))1 and c.913G>T (p.(Glu305*)),2 in individuals of Europea...",21,505,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.613C>T,"...05*)),2 in individuals of European ethnicity, and c.613C>T (p.(Arg205Cys))3 and c.1498C>T (p.(Arg500...",21,572,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.1498C>T,"...pean ethnicity, and c.613C>T (p.(Arg205Cys))3 and c.1498C>T (p.(Arg500*)),4 in Japanese. In one case...",21,602,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.560T>C,...haplotype in which a variant occurs is important: c.560T>C (p.(Val187Ala)) has no effect on FMO3 act...,21,708,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.472G>A,...occurs in cis with the common polymorphic variant c.472G>A (p.(Glu158Lys)) it severely affects enzym...,21,827,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.183C>A,"... FMO3 have been identified.10 Of these, only one, c.183C>A (p.(Asn61Lys)), which occurs at low frequ...",21,1211,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.472G>A,"... However, some polymorphic variants, for example, c.472G>A (p.(Glu158Lys)) and c.923A>G (p.(Glu308Gl...",21,1368,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.923A>G,"...riants, for example, c.472G>A (p.(Glu158Lys)) and c.923A>G (p.(Glu308Gly)), when present in cis, can...",21,1397,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.1585-1G>A,"...20+1G>A variants (legacy names) are designated as c.1585-1G>A and c.2988+1G>A, respectively, accordi...",20,1202,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2988+1G>A,"... (legacy names) are designated as c.1585-1G>A and c.2988+1G>A, respectively, according to the HGVS n...",20,1218,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1624G>T, G542X	c.1624G>T	p.Gly542*,162,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1652G>A, G551D	c.1652G>A	p.Gly551Asp,163,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3909C>G, N1303K	c.3909C>G	p.Asn1303Lys,164,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3846G>A, W1282X	c.3846G>A	p.Trp1282*,165,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.489+1G>T, 621+1G>T	c.489+1G>T	 ,166,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.178G>T, E60X	c.178G>T	p.Glu60*,168,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.254G>A, G85E	c.254G>A	p.Gly85Glu,169,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.579+1G>T, 711+1G>T	c.579+1G>T	 ,171,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1040G>C, R347P	c.1040G>C	p.Arg347Pro,172,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1364C>A, A455E	c.1364C>A	p.Ala455Glu,173,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1477C>T, Q493X	c.1477C>T	p.Gln493*,174,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1657C>T, R553X	c.1657C>T	p.Arg553*,176,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1679G>C, R560T	c.1679G>C	p.Arg560Thr,177,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1766+1G>A, 1898+1G>A	c.1766+1G>A	 ,178,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2657+5G>A, 2789+5G>A	c.2657+5G>A	 ,180,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2988+1G>A, 3120+1G>A	c.2988+1G>A	 ,181,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3484C>T, R1162X	c.3484C>T	p.Arg1162*,183,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.115C>T, Q39X	c.115C>T	p.Gln39*,186,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.200C>T, P67L	c.200C>T	p.Pro67Leu,187,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.223C>T, R75X	c.223C>T	p.Arg75*,188,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.273+1G>A, 405+1G>A	c.273+1G>A	 ,189,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.274-1G>A, 406-1G>A	c.274-1G>A	 ,190,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.274G>T, E92X	c.274G>T	p.Glu92*,191,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.274G>A, E92K	c.274G>A	p.Glu92Lys,192,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.292C>T, Q98X	c.292C>T	p.Gln98*,193,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.328G>C, D110H	c.328G>C	p.Asp110His,195,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.349C>T, R117C	c.349C>T	p.Arg117Cys,196,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.532G>A, G178R	c.532G>A	p.Gly178Arg,201,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.579+5G>A, 711+5G>A	c.579+5G>A	 ,203,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.580-1G>T, 712-1G>T	c.580-1G>T	 ,204,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.595C>T, H199Y	c.595C>T	p.His199Tyr,205,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.613C>T, P205S	c.613C>T	p.Pro205Ser,206,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.658C>T, Q220X	c.658C>T	p.Gln220*,208,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.988G>T, G330X	c.988G>T	p.Gly330*,211,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1000C>T, R334W	c.1000C>T	p.Arg334Trp,212,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1013C>T, T338I	c.1013C>T	p.Thr338Ile,214,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1040G>A, R347H	c.1040G>A	p.Arg347His,217,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1116+1G>A, 1248+1G>A	c.1116+1G>A	 ,219,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1202G>A, W401X(TAG)	c.1202G>A	p.Trp401*,221,13,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1203G>A, W401X(TGA)	c.1203G>A	p.Trp401*,222,13,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1209+1G>A, 1341+1G>A	c.1209+1G>A	 ,223,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1393-1G>A, 1525-1G>A	c.1393-1G>A	 ,225,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1397C>A, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1397C>G, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,21,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1466C>A, S489X	c.1466C>A	p.Ser489*,228,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1475C>T, S492F	c.1475C>T	p.Ser492Phe,229,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1558G>T, V520F	c.1558G>T	p.Val520Phe,231,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1585-1G>A, 1717-1G>A	c.1585-1G>A	 ,232,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1585-8G>A, 1717-8G>A	c.1585-8G>A	 ,233,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1646G>A, S549N	c.1646G>A	p.Ser549Asn,235,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1654C>T, Q552X	c.1654C>T	p.Gln552*,237,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1675G>A, A559T	c.1675G>A	p.Ala559Thr,238,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1680-1G>A, 1812-1G>A	c.1680-1G>A	 ,240,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1679G>A, R560K	c.1679G>A	p.Arg560Lys,241,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1753G>T, E585X	c.1753G>T	p.Glu585*,242,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2125C>T, R709X	c.2125C>T	p.Arg709*,247,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2290C>T, R764X	c.2290C>T	p.Arg764*,252,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2464G>T, E822X	c.2464G>T	p.Glu822*,254,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2490+1G>A, 2622+1G>A	c.2490+1G>A	 ,255,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2491G>T, E831X	c.2491G>T	p.Glu831*,256,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2537G>A, W846X	c.2537G>A	p.Trp846*,257,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2538G>A, W846X(2670TGG>TGA)	c.2538G>A	p.Trp846*,258,21,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2551C>T, R851X	c.2551C>T	p.Arg851*,259,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2834C>T, S945L	c.2834C>T	p.Ser945Leu,261,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2668C>T, Q890X	c.2668C>T	p.Gln890*,263,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2908G>C, G970R	c.2908G>C	p.Gly970Arg,266,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2988G>A, 3120G>A	c.2988G>A	 ,267,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2989-1G>A, 3121-1G>A	c.2989-1G>A	 ,268,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3196C>T, R1066C	c.3196C>T	p.Arg1066Cys,272,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3197G>A, R1066H	c.3197G>A	p.Arg1066His,273,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3266G>A, W1089X	c.3266G>A	p.Trp1089*,275,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3276C>A, Y1092X	c.3276C>A	p.Tyr1092*,276,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3310G>T, E1104X	c.3310G>T	p.Glu1104*,277,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3472C>T, R1158X	c.3472C>T	p.Arg1158*,278,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3587C>G, S1196X	c.3587C>G	p.Ser1196*,279,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3611G>A, W1204X(3743G>A)	c.3611G>A	p.Trp1204*,280,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3612G>A, W1204X(3744G>A)	c.3612G>A	p.Trp1204*,281,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3718-2477C>T, 3849+10kbC>T	c.3718-2477C>T	p.(?),283,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3731G>A, G1244E	c.3731G>A	p.Gly1244Glu,284,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3752G>A, S1251N	c.3752G>A	p.Ser1251Asn,286,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3873+1G>A, 4005+1G>A	c.3873+1G>A	 ,288,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3937C>T, Q1313X	c.3937C>T	p.Gln1313*,290,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.350G>A, R117H	c.350G>A	p.Arg117His,296,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2930C>T, S977F	c.2930C>T	p.Ser977Phe,303,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3205G>A, G1069R	c.3205G>A	p.Gly1069Arg,305,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3209G>A, R1070Q	c.3209G>A	p.Arg1070Gln,306,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3454G>C, D1152H	c.3454G>C	p.Asp1152His,307,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.91C>T, R31C	c.91C>T	p.Arg31Cys,312,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.220C>T, R74W	c.220C>T	p.Arg74Trp,313,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.224G>A, R75Q	c.224G>A	p.Arg75Gln,314,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1727G>C, G576A	c.1727G>C	p.Gly576Ala,317,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2002C>T, R668C	c.2002C>T	p.Arg668Cys,318,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2260G>A, V754M	c.2260G>A	p.Val754Met,319,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2991G>C, L997F	c.2991G>C	p.Leu997Phe,320,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3208C>T, R1070W	c.3208C>T	p.Arg1070Trp,322,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3485G>T, R1162L	c.3485G>T	p.Arg1162Leu,323,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3808G>A, D1270N	c.3808G>A	p.Asp1270Asn,325,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3208C>T,[R74W;R1070W;D1270N]c.[220C>T;c.3208C>T;3808G>A,341,31,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2657+5G>A,"...y542★…); LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable dise...",396,113,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1523T>G,...e508del due to the presence of the variant F508C (c.1523T>G); false homozygosity for p.Ile507del due...,480,230,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1519A>G,...07del due to the presence of p.Ile507Val (I597V) (c.1519A>G),480,321,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.55G>C,...ously reported rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amino-acid variant is b...,92,771,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
c.161A>G,...eflecting an earlier report of NM_022437.2(ABCG8):c.161A>G (p.Tyr54Cys) (r2~0.2 between rs4299376:G>...,92,1069,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
c.1810C>G,... in intron 10 and rs6720173:G>C NM_022436.2(ABCG5)c.1810C>G (p.Gln604Glu). The ABCG5/ABCG8 transport...,92,1293,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
c.404C>A,"HSPB1 was identified, a c.404C>A transversion resulted in p.(Ser135Tyr) am...",83,25,F1000Res_2015_Feb_26_4_53.txt
c.2722G>T,11	c.2722G>T	4	11	c.5645C>G	1,60,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5645C>G,11	c.2722G>T	4	11	c.5645C>G	1,60,19,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5682C>G,11	c.1291_1292insT	1	11	c.5682C>G	1,61,25,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.191G>A,5	c.191G>A	1	6	c.516 + 1G>T	1,70,3,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.514C>T,8	c.514C>T	1	8	c.658_659delGT	2,71,3,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5080G>T,18	c.5080G>T	1	10	c.1813insA	1,73,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5346G>A,22	c.5346G>A	1	15	c.7436_7437-2delAGAT	1,75,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5503C>T,24	c.5503C>T	1	16	c.7734_7740del6ins9	2,76,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.9117G>A,23	c.9117G>A	2,80,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.692C>T,11	c.692C>T	1	10	c.1385A>G	1,83,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1385A>G,11	c.692C>T	1	10	c.1385A>G	1,83,18,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1258G>T,11	c.1258G>T	1	15	c.7469T>C	1,84,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.7469T>C,11	c.1258G>T	1	15	c.7469T>C	1,84,19,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1486C>T,11	c.1486C>T	1	18	c.8111C>T	1,85,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8111C>T,11	c.1486C>T	1	18	c.8111C>T	1,85,19,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.4987-3C>G,17	c.4987-3C>G	1	21	c.8723T>G	1,86,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8723T>G,17	c.4987-3C>G	1	21	c.8723T>G	1,86,21,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5194-25A>C,19(I)	c.5194-25A>C	1,87,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5216A>G,20	c.5216A>G	1,88,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5435C>G,23	c.5435C>G	1,89,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.4987-3C>G,"...Vs had mutation probabilities below 20%. The UVs: c.4987-3C>G (putative splice variant), and c.5216A...",152,130,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5216A>G,"...e UVs: c.4987-3C>G (putative splice variant), and c.5216A>G in BRCA1 were the only two UVs with prob...",152,173,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.692C>T,11	c.692C>T	p.T231 M	1	59.9	17.8	Y	N/N	2	ND	N	Unknown...,156,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1258G>T,11	c.1258G>T	p.D420Y	1	6.5	10.5	Y	N/Y	3	ND	N	Unknown	...,157,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1486C>T,11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	...,158,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.4987-3C>G,17	c.4987-3C>G	NA		96.9	37.6	–	–	0	ND	ND,159,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5194-25A>C,20	c.5194-25A>C	NA	1	14.0	17.4	–	–	0	ND	ND,160,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5216A>G,20	c.5216A>G	p.D1739G	1	97.3	32.5	Y	Y/Y	2	ND	ND	Cance...,161,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5435C>G,23	c.5435C>G	p.P1812R	1	4.6	7.5	Y	Y/Y	0	ND	ND,162,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1385A>G,10	c.1385A>G	p.E462G	1	37.8	17.8	Y	Y/N	35	N	Y	Neutral...,165,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.7469T>C,15	c.7469T>C	p.I2490T	1	13.6	19.9	Y	N/N	238	ND	ND,166,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8111C>T,18	c.8111C>T	p.S2704F	1	11.5	7.3	Y	N/N	1	ND	ND,167,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8723T>G,21	c.8723T>G	p.V2908G	1	1.2	9.8	N	Y/N	8	N	N	Neutral	[...,168,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.-32-13T>G,"...n mutation among Caucasian children and adults is c.-32-13T>G (IVS1), a splicing defect which allows...",23,65,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.1935C>A,"... Hirschhorn and Huie, 1999), and a common defect, c.1935C>A (p.Asp645Glu), is shared by Chinese pati...",25,149,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.2560C>T,"...). The most common mutation in African-Americans, c.2560C>T (p.Arg854Ter), most likely originated in...",25,284,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.-135T>C,NM_145740.3:c.-135T>C,186,14,Front_Genet_2014_Nov_14_5_391.txt
c.331A>G,"...2755:c.167A>C_p.Q56P (0.13,1125, PIK3CA:NM 006218:c.331A>G p.K111E [0.13,765]), and CTNNB1:NM_001904...",77,191,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
c.1155A>C,"...dicating third-degree relatives; S4 and A5 (MCCC1 c.1155A>C mutation) had a PI_HAT of 0.09, indicati...",50,600,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.974T>G,"...cating fourth-degree relatives; A5 and S20 (MCCC1 c.974T>G mutation) have a PI_HAT of 0.09, indicati...",50,696,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.295G>C,...nding chromosomal region. Cases S25 and S8 (MCCC2 c.295G>C mutation) had identical genotypes at all ...,50,1446,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1065A>T,...ting identity by descent. Cases A7 and A11 (MCCC2 c.1065A>T mutation) had identical genotypes at 35 ...,50,1561,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1015G>A,...S9 and S10 (both compound heterozygotes for MCCC2 c.1015G>A mutation) had dissimilar genotypes in th...,50,1709,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1315G>A,MCCC1	1	A2	F	Homozygous	c.1315G>A	p.Val438Met	Nonsyn	This study,88,25,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1750C>T,A3	F	Compound Het.	c.1750C>T*,89,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1894C>T,c.1894C>T	p.Gln584X,90,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1731+4A>G,"A4	F	Homozygous	c.1731+4A>G	Intronic, splice region	UNK	This study...",92,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1155A>C,A5	F	Compound Het.	c.1155A>C*,93,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.974T>G,c.974T>G*	p.Arg385Ser,94,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.841C>T,A9	F	Compound Het.	c.841C>T; c.558delA	p.Arg281X,96,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.834A>G,c.834A>G	p.Val397Glyfs*19,99,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.539G>T,A19	F	Compound Het.	c.539G>T; c.558delA	p.Gly180Val,102,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.872C>T,A23	F	Compound Het.	c.872C>T; UND	p.Ala291Val	Nonsyn	This study,105,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.866C>T,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.974T>G,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,33,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1155A>C,"3	S4	F	Homozygous	c.1155A>C*	p.Arg385Ser	Nonsyn	Refs. 15,16",110,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1594G>C,S5	F	Homozygous	c.1594G>C*	p.Asp532His	Nonsyn/splicing	Ref. 15,111,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1310T>C,"S6	M	Homozygous	c.1310T>C*	p.Leu437Pro	Nonsyn	Refs. 4,15",112,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1114C>T,S26	F	Compound Het.	c.1114C>T,113,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1882G>T,c.1882G>T	p.Gln372X,114,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.592C>T,MCCC2	1	A6	F	Homozygous	c.592C>T	p.Gln198X	Stop	This study,117,25,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1065A>T,A7	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,118,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1065A>T,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.302C>T,A13	F	Compound Het.	c.302C>T; UND	p.Ser101Phe	Nonsyn	This study,120,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.214C>T,A14	F	Compound Het.	c.214C>T*; UND	p.Arg72X	Nonsyn	This study,121,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1367C>T,A16	F	Homozygous	c.1367C>T	p.Ala456Val	Nonsyn	Ref. 6,122,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.599T>A,c.599T>A*	p.Ser173Phefs*25,124,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1488G>C,A22	F	Compound Het.	c.1488G>C,126,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.994C>T,c.994C>T	p.Ser173Phefs*25,131,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.464G>A,S21	M	Compound Het.	c.464G>A*,133,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.929C>G,c.929C>G*	p.Arg155Gln,134,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.295G>C,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.295G>C,"3	S8	M	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Refs. 3,15",139,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1015G>A,"S9	M	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Refs. 15,17",140,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1015G>A,S10	F	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Ref. 15,141,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1054G>A,"S17	F	Homozygous	c.1054G>A	p.Gly352Arg	Nonsyn/splicing	Refs. 6,20",142,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1309A>G,"S23	M	Compound Het.	c.1309A>G*; UND	p.Ile437Val	Nonsyn	Refs. 14,15",143,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.116C>T,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1537C>T,1	CH	c.1537C>,226,6,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1543G>A,c.1543G>A	p.R512,228,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1543G>A,MTI-498	1	H	c.1543G>A,238,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1535G>A,JS_D	1	H	c.1535G>A	p.R512Q	Yes,244,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1600T>G,JBS-011	2	CH	c.1600T>,248,15,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1862G>A,c.1862G>A	p.Y534,250,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1688G>A,MTI-008	4	H	c.1688G>A	p.R563H	Yes,258,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1738A>G,MTI-627	3 (1 died)	H	c.1738A>G	p.K580E	Yes,264,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1921T>C,c.1921T>,271,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1921T>C,c.1921T>,281,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1051C>T,c.1051C>,290,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1051C>T,c.1051C>,300,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1303C>T,c.1303C>T	p.R435*	Yes,308,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,315,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,325,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,335,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,345,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1922T>A,c.1922T>,355,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1922T>A,2	Ht	c.1922T>A,363,7,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2156A>G,K8103	2	H	c.2156A>G	p.D719G	Yes,370,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.143G>A,A2229	1	H	c.143G>A	p.R48K	Yes,393,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4714G>T,JS_3	1	H	c.4714G>T	p.E1572*	Yes,403,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,410,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,420,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,431,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,439,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,447,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,455,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5932G>A,c.5932G>A,457,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5824C>T,MTI-133	2 (2 died)	H	c.5824C>T	p.Q1942*	Yes,463,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1888T>C,A1371	2	H	c.1888T>C	p.S630P	Yes,468,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2461G>A,ND	Ht	c.2461G>A	p.G821S	No	digenic	Egyptian,476,8,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2439+5G>C,JS-05	1	H	c.2439+5G>C	p.I775_A813del	ND,481,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1649A>G,JS_F1	3	H	c.1649A>G	p.Q550R	Yes,486,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2161C>T,JBS-006	1	H	c.2161C>T	p.P721S	Yes,491,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3055C>T,c.3055C>,500,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3056G>A,c.3056G>,511,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3364C>T,c.3364C>,521,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3364C>T,c.3364C>,532,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4652T>C,F871	1	H	c.4652T>C	p.L1551P	Yes,541,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4582C>T,c.4582C>T	p.R1528C	Yes,548,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4258G>A,MTI-127	1	CH	c.4258G>,554,15,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.342-2A>G,c.342-2A>,600,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.342-2A>G,c.342-2A>,611,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.869+1G>A,c.869+1G>,628,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.33+2T>G,MTI-429	5 (1 died)	H	c.33+2T>G	ND	Yes,637,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.376G>A,c.376G>,650,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.376G>A,c.376G>,661,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.380C>T,c.380C>T	p.A127V	Yes,671,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.389A>G,c.389A>,677,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.389A>G,c.389A>,688,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.389A>G,c.389A>,697,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,706,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,713,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.7978C>T,c.7978C>T	p.R2660*	Yes,717,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1437G>C,c.1437G>C	p.R479S	No	digenic	F (Emirati,741,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2773C>T,ND	1	H	c.2773C>T	p.R925*	Yes,753,9,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.875T>C,...characterized FRMD7 missense variant (NM_194277.2:c.875T>C) detected in a Japanese family with XLCIN...,17,1205,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,"...ons.9 Sequencing FRMD7 revealed a T>C transition (c.875T>C) in exon 9 (Figure 1b), which causes a co...",21,727,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,"...idelines.10,11 We accordingly speculated that the c.875T>C variant of FRMD7 is associated with ICN i...",21,1593,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,The missense variant c.875T>C has a single-nucleotide polymorphism (SNP...,23,22,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,The c.875T>C variant in patients with congenital nysta...,25,5,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,"... by II:1, II:2 and II:3. Arrow marks the variant, c.875T>C. (c) Cross-species multiple alignment of ...",39,398,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.207C>A,"...ase. Here, we report a novel hemizygous mutation, c.207C>A (Phe69 Leu), which caused a mild/late-ons...",14,1082,Hum_Genome_Var_2015_Nov_12_2_15044.txt
c.207C>A,"...ntified one hemizygous mutation in exon 2 of GLA, c.207C>A (p. Phe69 Leu). The mutation was absent f...",24,305,Hum_Genome_Var_2015_Nov_12_2_15044.txt
c.936+919G>A,... a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,171,111,Hum_Genome_Var_2015_Nov_12_2_15044.txt
c.307C>T,"...imit in Patient no. 19. Patient no. 12, who had a c.307C>T mutation in the paired domain (PD), exhib...",23,1021,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,"...reduction of amplitude. Patient no. 19, who had a c.802G>T mutation in the proline/serine/threonine-...",23,1168,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.949C>T,"... a normal ERG response. Patient no. 21, who had a c.949C>T mutation in PST, exhibited subnormal cone...",23,1296,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.79C>T,"...ings (data not shown). Novel mutations, including c.79C>T (p.Gln27X), c.109_110insG (p.Ala2GlyfsX19)...",26,696,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,"...+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identifi...",26,802,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.131G>A,"...s previously reported, the two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) wer...",26,928,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,... two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were found in two sporadic pa...,26,954,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	...,51,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.131G>A,2	 	Sporadic	Exon5	c.131G>A	Missense	p.Arg44Gln	PD	No	21	M	Total/tota...,52,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.79C>T,3	 	Sporadic	Exon5	c.79C>T	Nonsense	p.Gln27X	PD	Yes	9	M	Total/total	−...,53,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.307C>T,12	 	Sporadic	Exon6	c.307C>T	Nonsense	p.Arg103X	PD	Yes	13	M	Total/tota...,63,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.607C>T,14	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	11	M	Total/tot...,65,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.607C>T,15	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	9	F	Partial/pa...,66,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.718C>T,16	 	Sporadic	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	27	F	Total/tota...,67,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.718C>T,17	4	Familial	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	29	M	Total/tota...,68,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.718C>T,18	4	 	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	5	F	Total/total...,69,14,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,19	 	Sporadic	Exon10	c.802G>T	Nonsense	p.Glu268X	PST	Yes	6	F	Total/tota...,70,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.829C>T,20	 	Sporadic	Exon10	c.829C>T	Nonsense	p.Gln277X	PST	Yes	13	F	Total/tot...,71,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.949C>T,21	 	Sporadic	Exon11	c.949C>T	Nonsense	p.Arg317X	PST	Yes	10	M	Total/tot...,72,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.1330C>T,...atient 2—c.758del [p.(Gly253Alafs*16)]; patient 3—c.1330C>T [p.(Gln444*)]. All mutations are predica...,18,649,Hum_Genome_Var_2016_Oct_13_3_16033.txt
c.2386C>T,"...tted variant predicted a premature stop mutation (c.2386C>T; p.R796X), whereas the maternally transm...",3,2449,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...mitted variant predicted a missense substitution (c.5560G>A; p.D1854N) at a conserved residue within...,3,2548,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.2386C>T,...ritance pattern. The first variant in PI4KA was a c.2386C>T mutation in exon 20 (NM_058004.3) that i...,46,1447,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,"...n of translation (p.R796X). The second variant, a c.5560G>A in exon 48 is predicted to result in a m...",46,1592,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.2386C>T,"...istent with autosomal recessive inheritance, with c.2386C>T inherited from the father (I-1) and c.55...",46,2436,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...ith c.2386C>T inherited from the father (I-1) and c.5560G>A from the mother (I-2) (Fig. 2B),46,2482,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...ng of pseudogene sequence. Reads that support the c.5560G>A variant (here shown on the +ve genomic s...,62,845,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,"... harbour the dinucleotide change, indicating that c.5560G>A is unlikely to be a mismapping artefact....",62,978,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.2386C>T,"...nces does not extend to the region harbouring the c.2386C>T variant, when viewing the exome data for...",67,255,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,"...6C>T variant, when viewing the exome data for the c.5560G>A variant in IGV one sees a small percenta...",67,310,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...C>GT) (Fig. 2C). None of the reads supporting the c.5560G>A mutation had this dinucleotide alteratio...,67,614,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...udogene sequences at its 3′ end (Fig. 2D) and the c.5560G>A variant was still clearly visible (Suppl...,67,898,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...urther evidence (i) that the maternally inherited c.5560G>A mutation is present in the functional co...,70,228,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.2386C>T,...seudogenes and (ii) that the paternally inherited c.2386C>T mutation is not subjected to significant...,70,370,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.1824C>T,...l nuclei after 70 weeks of expression of the LMNA c.1824C>T mutation showed severe distortion with m...,5,1579,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,"...ygous point mutation in exon 11 of the LMNA gene (c.1824C>T, p.G608G). Although this mutation does n...",10,321,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,... that specifically expresses the most common LMNA c.1824C>T HGPS mutation in neurons as well as in c...,14,616,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,Expression of the LMNA c.1824C>T mutation in mic,23,24,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,HGPS animals expressed the LMNA c.1824C>T mutation from embryonic day 12.5 until p...,32,33,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,"... 1). In spite of long-term expression of the LMNA c.1824C>T mutation, 90-week HGPS animals did not e...",37,437,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,...imals (Fig. 1P and Q). Twenty or 90 weeks of LMNA c.1824C>T mutation expression did not cause any ma...,37,1510,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,...defects in the heart after 20 or 74 weeks of LMNA c.1824C>T mutation expression (Supplementary Mater...,37,2647,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,"...on of the common progeroid lamin A mutation, LMNA c.1824C>T; p.G608G, to test the hypothesis that ne...",87,540,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1732C>T,"...ed fibroblast lines with mutations in AP5Z1 : (i) c.1732C>T (p.Q578*), (ii) c.[412C>T];[1322G>A] (p....",18,495,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
c.6100C>T,"...SPG11 patient from Morocco carries the homozygous c.6100C>T (p.Arg2034*) nonsense variant (6), and t...",83,370,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
c.2431C>T,...ase originated from Latvia and has a heterozygous c.2431C>T (p.Q811*) variant in trans of a deletion...,83,487,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
